Добірка наукової літератури з теми "MiR-3192-5p"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "MiR-3192-5p".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "MiR-3192-5p":
You, Qi, Yuan Yao, Jinyu Wu, Congcong Cheng, Yunxiu Li, and Haitao Yuan. "YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis." Biomedicine & Pharmacotherapy 129 (September 2020): 110339. http://dx.doi.org/10.1016/j.biopha.2020.110339.
You, Qi, Yuan Yao, Jinyu Wu, Congcong Cheng, Yunxiu Li, and Haitao Yuan. "Retraction notice to "YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis"." Biomedicine & Pharmacotherapy 141 (September 2021): 111986. http://dx.doi.org/10.1016/j.biopha.2021.111986.
McLaughlin, Tracey, Ingela Schnittger, Anna Nagy, Elizabeth Zanley, Yue Xu, Yanqiu Song, Koen Nieman, et al. "Relationship Between Coronary Atheroma, Epicardial Adipose Tissue Inflammation, and Adipocyte Differentiation Across the Human Myocardial Bridge." Journal of the American Heart Association 10, no. 22 (November 16, 2021). http://dx.doi.org/10.1161/jaha.121.021003.
HAN LEE, WAI, BENJAMIN NELSON, APRIL M. TEAGUE, KEVIN R. SHORT, and JEANIE B. TRYGGESTAD. "1174-P: Circulating MicroRNA in Youth with Type 1 Diabetes in Response to a Meal Challenge." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1174-p.
Дисертації з теми "MiR-3192-5p":
Brochen, Célia. "Caractérisation des cibles de miARNs sensibilisateurs à l'action de la chimiothérapie en vue de la proposition de nouvelles stratégies thérapeutiques dans les cancers de l'ovaire (SensimiRs)." Electronic Thesis or Diss., Normandie, 2024. http://www.theses.fr/2024NORMC401.
Although the majority of ovarian cancer patients initially respond to platinum-based chemotherapy, most of them relapse and develop chemoresistance, leading to poor 5-year survival. In this context, it is important to understand the molecular mechanisms involved in chemoresistance in order to develop new therapeutic approaches. In this context, a functional screening of a miRNA library identified several microRNAs (miRNAs) that sensitize two chemoresistant ovarian cancer lines (IGROV1-R10 and SKOV3) to the action of cisplatin, including miR-3192-5p, which induces massive cell death by apoptosis and has never been previously studied. The chemosensitizing effect of this miRNA was then validated on a third chemoresistant ovarian cancer line (OAW42-R). Using an approach combining bioinformatics and functional study, we observed that miR-3192-5p modulates the expression of several proteins involved in DNA damage response and repair mechanisms. Among these targets, we have demonstrated that the ERCC1 protein is a key determinant of the chemosensitizing effect of miR-3192-5p in the IGROV1-R10 and OAW42-R ovarian cancer lines. Preliminary results show that sensitization of SKOV3 cells to cisplatin action may be related to inhibition of CHEK1, whose expression is decreased in response to miR-3192-5p. In summary, this work has enabled us to identify new miRNAs involved in chemoresistance in ovarian cancers, and to characterize more precisely the role of miR-3192-5p and certain targets involved in its chemosensitizing action, opening the way to the proposal of new therapeutic strategies to improve the management of these cancers